Literature DB >> 21046451

Expression of trophic peptides and their receptors in chromaffin cells and pheochromocytoma.

Erwan Thouennon1, Alice Pierre, Laurent Yon, Youssef Anouar.   

Abstract

Pheochromocytomas are catecholamine-producing tumors arising from chromaffin cells of the adrenal medulla or extra-adrenal location. Along with catecholamines, tumoral cells produce and secrete elevated quantities of trophic peptides which are normally released in a regulated manner by the normal adrenal medulla. Among these peptides, the amounts of pituitary adenylate cyclase-activating polypeptide (PACAP), adrenomedullin (AM), and neuropeptide Y (NPY) are particularly high. These peptides can exert endocrine, paracrine or autocrine effects in numerous cell types. In particular, they have been shown to be involved in cell proliferation and survival, catecholamine production and secretion, and angiogenesis. Some of these processes are exacerbated in pheochromocytomas, raising the possibility of the involvement of trophic peptides. Here, we review the expression levels of NPY, PACAP, and AM and theirs receptors in chromaffin cells and pheochromocytomas, and address their possible implication in the adrenal medulla tumorigenesis and malignant development of pheochromocytomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046451     DOI: 10.1007/s10571-010-9594-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  70 in total

1.  PACAP release from the canine adrenal gland in vivo: its functional role in severe hypotension.

Authors:  Stéphane Lamouche; Nobuharu Yamaguchi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-10-31       Impact factor: 3.619

Review 2.  Adrenomedullin and its related peptide.

Authors:  Tatsuo Shimosawa; Toshiro Fujita
Journal:  Endocr J       Date:  2005-02       Impact factor: 2.349

3.  Molecular genetic analysis of a human neuropeptide Y receptor. The human homolog of the murine "Y5" receptor may be a pseudogene.

Authors:  P M Rose; J S Lynch; S T Frazier; S M Fisher; W Chung; P Battaglino; Z Fathi; R Leibel; P Fernandes
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

4.  Neuropeptide Y functions as a neuroproliferative factor.

Authors:  D E Hansel; B A Eipper; G V Ronnett
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

5.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

6.  Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.

Authors:  P deS Senanayake; J Denker; E L Bravo; R M Graham
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.

Authors:  Zhenhua Miao; Kathryn E Luker; Bretton C Summers; Rob Berahovich; Mahaveer S Bhojani; Alnawaz Rehemtulla; Celina G Kleer; Jeffrey J Essner; Aidas Nasevicius; Gary D Luker; Maureen C Howard; Thomas J Schall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

8.  Neuropeptide Y in the adrenal gland: characterization, distribution and drug effects.

Authors:  M E de Quidt; P C Emson
Journal:  Neuroscience       Date:  1986-11       Impact factor: 3.590

9.  Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y.

Authors:  T D Hexum; L R Russett
Journal:  Neuropeptides       Date:  1989-01       Impact factor: 3.286

10.  Distribution of the VPAC2 receptor in peripheral tissues of the mouse.

Authors:  Anthony J Harmar; W John Sheward; Christine F Morrison; Beatrice Waser; Mathias Gugger; Jean Claude Reubi
Journal:  Endocrinology       Date:  2003-11-14       Impact factor: 4.736

View more
  4 in total

1.  Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomy.

Authors:  Pang-Hu Zhou; Lei Shi; Wei Hu; Xiao-Bin Zhang; Wei Wang; Li-Jun Zhang
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

2.  Plasma concentrations of adrenomedullin and atrial and brain natriuretic peptides in patients with adrenal pheochromocytoma.

Authors:  Wei Hu; Lei Shi; Pang-Hu Zhou; Xiao-Bin Zhang
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

3.  Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas.

Authors:  Ozgur Mete; Arthur S Tischler; Ronald de Krijger; Anne Marie McNicol; Graeme Eisenhofer; Karel Pacak; Shereen Ezzat; Sylvia L Asa
Journal:  Arch Pathol Lab Med       Date:  2014-02       Impact factor: 5.534

Review 4.  Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma.

Authors:  Annika M A Berends; Graeme Eisenhofer; Lauren Fishbein; Anouk N A V D Horst-Schrivers; Ido P Kema; Thera P Links; Jacques W M Lenders; Michiel N Kerstens
Journal:  Cancers (Basel)       Date:  2019-08-06       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.